Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,740 | -10,323 | -4,758 | -19,103 | -12,474 |
| Depreciation Amortization | 221 | 144 | 72 | 302 | 225 |
| Other Working Capital | 178 | -2,556 | -1,150 | 301 | -1,110 |
| Other Operating Activity | 704 | 615 | 49 | 536 | 15 |
| Operating Cash Flow | $-16,638 | $-12,120 | $-5,787 | $-17,965 | $-13,345 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,077 | 10,015 | 4,933 | -15,652 | N/A |
| PPE Investments | -4 | -4 | -4 | -42 | -43 |
| Investing Cash Flow | $15,074 | $10,011 | $4,930 | $-15,694 | $-43 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,919 | N/A | N/A | N/A | 9 |
| Other Financing Activity | 6,628 | 6,667 | 3,896 | 9,388 | 4,845 |
| Financing Cash Flow | $22,547 | $6,667 | $3,896 | $9,388 | $4,854 |
| Exchange Rate Effect | 121 | -204 | 70 | 1,505 | 1,714 |
| Beginning Cash Position | 8,695 | 8,677 | 8,624 | 31,739 | 31,615 |
| End Cash Position | 29,798 | 13,031 | 11,733 | 8,974 | 24,796 |
| Net Cash Flow | $21,103 | $4,354 | $3,109 | $-22,765 | $-6,819 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,638 | -12,120 | -5,787 | -17,965 | -13,345 |
| Capital Expenditure | -4 | -4 | -4 | -42 | -43 |
| Free Cash Flow | -16,642 | -12,123 | -5,791 | -18,007 | -13,387 |